Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EPOPROSTENOL Cause Deep vein thrombosis? 27 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Deep vein thrombosis have been filed in association with EPOPROSTENOL (EPOPROSTENOL). This represents 0.2% of all adverse event reports for EPOPROSTENOL.

27
Reports of Deep vein thrombosis with EPOPROSTENOL
0.2%
of all EPOPROSTENOL reports
9
Deaths
24
Hospitalizations

How Dangerous Is Deep vein thrombosis From EPOPROSTENOL?

Of the 27 reports, 9 (33.3%) resulted in death, 24 (88.9%) required hospitalization, and 5 (18.5%) were considered life-threatening.

Is Deep vein thrombosis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EPOPROSTENOL. However, 27 reports have been filed with the FAERS database.

What Other Side Effects Does EPOPROSTENOL Cause?

Dyspnoea (2,744) Headache (2,425) Diarrhoea (2,310) Nausea (2,016) Pain in jaw (1,928) Death (1,362) Flushing (1,256) Fatigue (1,133) Hospitalisation (1,078) Vomiting (1,068)

What Other Drugs Cause Deep vein thrombosis?

LENALIDOMIDE (3,286) RIVAROXABAN (3,180) TESTOSTERONE (2,213) APIXABAN (1,944) ETHINYL ESTRADIOL\ETONOGESTREL (1,577) RITUXIMAB (1,287) METHOTREXATE (1,146) DROSPIRENONE\ETHINYL ESTRADIOL (1,139) DEXAMETHASONE (1,067) ADALIMUMAB (1,056)

Which EPOPROSTENOL Alternatives Have Lower Deep vein thrombosis Risk?

EPOPROSTENOL vs EPTIFIBATIDE EPOPROSTENOL vs EPTINEZUMAB-JJMR EPOPROSTENOL vs EPTINEZUMAB\EPTINEZUMAB-JJMR EPOPROSTENOL vs EQUINE BOTULINUM NEUROTOXIN A/B/C/D/E/F/G IMMUNE FAB2 EPOPROSTENOL vs EQUINE THYMOCYTE IMMUNE GLOBULIN

Related Pages

EPOPROSTENOL Full Profile All Deep vein thrombosis Reports All Drugs Causing Deep vein thrombosis EPOPROSTENOL Demographics